BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...
BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
Meta Platforms Inc. is bringing prompt-based editing to the world of sound with a new model called SAM Audio that can segment individual sounds from complex audio recordings. The new model, available ...
Want to watch a movie with your family or friends, but still allow each person to use their own audio device? Microsoft is previewing a new feature that will allow Windows 11 users to share audio over ...
The Bluetooth LE-based feature will allow testers to broadcast audio across wireless headphones, speakers, and hearing aids. The Bluetooth LE-based feature will allow testers to broadcast audio across ...
After upgrading to 10.11.1, a regression has occurred where music playback is being cut off by three seconds at the beginning on clients that are not a Chrome browser when the client is required to ...
Safety primary endpoint achieved Median treatment duration of 4 months with a range of 2 to 12 months and three patients remain on trial RECIST data with apparent stable disease lasting over 4 months ...
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a $25 million injection into its cash-strapped coffers—but in doing so, the company is trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback